ArticleBioinformatics (Oxford, England)2018
Chromatin accessibility prediction via a hybrid deep convolutional neural network.
Article in Bioinformatics (Oxford, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
35 citing papers in PubMed.
- seqLens: Optimizing Language Models for Genomic Predictions.Molecular biology and evolution · 2026Article
- HPCSMN: A Classification Method of Chemotherapy Sensitivity of Hypopharyngeal Cancer Based on Multimodal Network.Interdisciplinary sciences, computational life sciences · 2026Article
- Early feature extraction drives model performance in high-resolution chromatin accessibility prediction.Genome research · 2026Article
- Predicting gene expression from DNA sequence using deep learning models.Nature reviews. Genetics · 2025Review
- Improved circulating tumor DNA identification for detection of esophageal squamous cell carcinoma by enzymatic methyl sequencing and hybrid neural network.Scientific reports · 2025Article
- EACVP: An ESM-2 LM Framework Combined CNN and CBAM Attention to Predict Anti-coronavirus Peptides.Current medicinal chemistry · 2025Article
- EpiGePT: a pretrained transformer-based language model for context-specific human epigenomics.Genome biology · 2024Article
- dHICA: a deep transformer-based model enables accurate histone imputation from chromatin accessibility.Briefings in bioinformatics · 2024Article
- ctGAN: combined transformation of gene expression and survival data with generative adversarial network.Briefings in bioinformatics · 2024Article
- Review
- Early detection of hepatocellular carcinoma via no end-repair enzymatic methylation sequencing of cell-free DNA and pre-trained neural network.Genome medicine · 2023Article
- The evolution and mutational robustness of chromatin accessibility in Drosophila.Genome biology · 2023Article
- Accurate Prediction of Anti-hypertensive Peptides Based on Convolutional Neural Network and Gated Recurrent unit.Interdisciplinary sciences, computational life sciences · 2022Article
- Modeling chromatin state from sequence across angiosperms using recurrent convolutional neural networks.The plant genome · 2022Article
- A review of deep learning applications in human genomics using next-generation sequencing data.Human genomics · 2022Review
- DeepCAGE: Incorporating Transcription Factors in Genome-wide Prediction of Chromatin Accessibility.Genomics, proteomics & bioinformatics · 2022Article
- SemanticCAP: Chromatin Accessibility Prediction Enhanced by Features Learning from a Language Model.Genes · 2022Article
- Interpretation of convolutional neural networks reveals crucial sequence features involving in transcription during fiber development.BMC bioinformatics · 2022Article
- Base-resolution prediction of transcription factor binding signals by a deep learning framework.PLoS computational biology · 2022Article
- Air Pollution and Perinatal Health in the Eastern Mediterranean Region: Challenges, Limitations, and the Potential of Epigenetics.Current environmental health reports · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Motivation: A majority of known genetic variants associated with human-inherited diseases lie in non-coding regions that lack adequate interpretation, making it indispensable to systematically discover functional sites at the whole genome level and precisely decipher their implications in a comprehensive manner. Although computational approaches have been complementing high-throughput biological experiments towards the annotation of the human genome, it still remains a big challenge to accurately annotate regulatory elements in the context of a specific cell type via automatic learning of the DNA sequence code from large-scale sequencing data. Indeed, the development of an accurate and interpretable model to learn the DNA sequence signature and further enable the identification of causative genetic variants has become essential in both genomic and genetic studies. Results: We proposed Deopen, a hybrid framework mainly based on a deep convolutional neural network, to automatically learn the regulatory code of DNA sequences and predict chromatin accessibility. In a series of comparison with existing methods, we show the superior performance of our model in not only the classification of accessible regions against background sequences sampled at random, but also the regression of DNase-seq signals. Besides, we further visualize the convolutional kernels and show the match of identified sequence signatures and known motifs. We finally demonstrate the sensitivity of our model in finding causative noncoding variants in the analysis of a breast cancer dataset. We expect to see wide applications of Deopen with either public or in-house chromatin accessibility data in the annotation of the human genome and the identification of non-coding variants associated with diseases. Availability and implementation: Deopen is freely available at https://github.com/kimmo1019/Deopen. Contact: ruijiang@tsinghua.edu.cn. Supplementary information: Supplementary data are available at Bioinformatics online.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.